Showing results (11-20 of 95) with videos related to

Sort By:
Pageof 10
Biochemical Pharmacology|April 27, 2010
Effects of gamma-glutamyl linker on DPP-IV resistance, duration of action and biological efficacy of acylated glucagon-like peptide-1Barry D Kerr, Peter R Flatt, Victor A Gault
Biochemical and Biophysical Research Communications|August 7, 2003
Glucose-dependent insulinotropic polypeptide analogues and their therapeutic potential for the treatment of obesity-diabetesVictor A Gault, Peter R Flatt, Finbarr P M O'Harte
Clinical Medicine Insights. Endocrinology and Diabetes|October 8, 2021
Therapeutic Potential of Peptides Derived from Animal Venoms: Current Views and Emerging Drugs for DiabetesAimee Coulter-Parkhill, Stephen McClean, Victor A Gault, et al.
European Journal of Pharmacology|December 29, 2009
Glucagon-like peptide-1 analogues enhance synaptic plasticity in the brain: a link between diabetes and Alzheimer's diseasePaula L McClean, Victor A Gault, Patrick Harriott, et al.
The Journal of Endocrinology|March 5, 2020
Ψ-Xenin-6 enhances sitagliptin effectiveness, but does not improve glucose toleranceSarah L Craig, Victor A Gault, Gerd Hamscher, et al.
Neuropeptides|November 11, 2003
Glucose-dependent insulinotropic polypeptide (GIP): anti-diabetic and anti-obesity potential?Victor A Gault, Finbarr P M O'Harte, Peter R Flatt
The Journal of Endocrinology|January 8, 2011
Comparison of sub-chronic metabolic effects of stable forms of naturally occurring GIP(1-30) and GIP(1-42) in high-fat fed miceVictor A Gault, David W Porter, Nigel Irwin, et al.
Peptides|November 26, 2008
Prolonged GIP receptor activation using stable mini-PEGylated GIP improves glucose homeostasis and beta-cell function in age-related glucose intoleranceBarry D Kerr, Nigel Irwin, Peter R Flatt, et al.
Biochemical Pharmacology|December 6, 2020
The methionine aminopeptidase 2 inhibitor, TNP-470, enhances the antidiabetic properties of sitagliptin in mice by upregulating xeninSarah L Craig, Victor A Gault, Peter R Flatt, et al.
Chemmedchem|November 10, 2012
(Val(8))GLP-1-Glu-PAL: a GLP-1 agonist that improves hippocampal neurogenesis, glucose homeostasis, and β-cell function in high-fat-fed miceRachael Lennox, David W Porter, Peter R Flatt, et al.
Pageof 10